{"result": {"id": "chatcmpl-993", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "**Bevacizumab** is a humanized monoclonal antibody that acts as an anti-angiogenic drug. It inhibits the activity of vascular endothelial growth factor (VEGF), suppressing neovascularization and targeting various conditions, including **AMD**, **cancer**, **mCNV**, **mCRC**, and **Cutaneous Malignant Melanoma**.  It has been approved for use in treating metastatic colorectal cancer and is also used in chemotherapy for this type of cancer. Bevacizumab influences the viability of human umbilical vein endothelial cells (HUVECs) and is effective in suppressing neovascularization, making it a valuable tool in various medical treatments. \n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743158630, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 132, "prompt_tokens": 295, "total_tokens": 427, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"BEVACIZUMAB\"\nDescription List: [\"A drug used to treat AMD\", \"A drug used to treat cancer\", \"A monoclonal antibody against VEGF\", \"A substance that influences HUVECs cell viability\", \"An anti-angiogenic drug used to treat ASPPC\", \"Anti-VEGF medication\", \"Bevacizumab is a humanized monoclonal antibody used for the treatment of metastatic colorectal cancer\", \"Bevacizumab is an anti-angiogenic drug\", \"Drug used for treatment of mCNV\", \"Drug used in chemotherapy for Cutaneous Malignant Melanoma\", \"Drug used in the study\", \"Drug used in the treatment of mCRC\", \"Drug used to suppress neovascularization\", \"Drug used to treat CNV\", \"Drug used to treat m-CNV\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_b240597aa2f4a1a9b6cefff40ea200de6d2b4531fa392b440ece0a0a849f29a9_v2"}